22 Nov 2011

UCB acquires Lectus Therapeutics’ key pharmaceutical assets

Read More
15 Nov 2011

UCB enters into strategic partnerships in clinical development with PAREXEL and PRA

Read More
8 Nov 2011

New data for Cimzia® (certolizumab pegol) showed a rapid and sustained response in Japanese rheumatoid arthritis (RA) patients unresponsive to or unable to take methotrexate (MTX) therapy

Read More
8 Nov 2011

Epratuzumab phase IIb data demonstrated sensitivity of BICLA, a novel BILAG-based composite endpoint

Read More
7 Nov 2011

New data from REALISTIC study showed Cimzia® (certolizumab pegol) provided rapid and sustained efficacy, over 28 weeks, in a broad population of patients with moderate to severe rheumatoid arthritis (RA) including those who discontinued prior anti-TNF the

Read More
7 Nov 2011

New RAPID 1 post-hoc analysis showed early response to Cimzia® (certolizumab pegol) at Week 12 was predictive of Week 52 response

Read More
27 Oct 2011

UCB Interim Report for the first nine months of 2011

Read More
24 Oct 2011

American Congress of Reumatology Annual Meeting

Read More
24 Oct 2011

UCB supports new epilepsy patient centre in Beijing and partners with Chinese association to open more

Read More
13 Oct 2011

Belgian Economic Mission to China

Read More
Subscribe to